Skip to main content
Chin Hur, MD, Gastroenterology, New York, NY

Chin Hur MD

Gastroenterology•New York, NY

Esophagus Disease, Gastrointestinal Cancer

Professor of Medicine

Request Appointment

  • 161 Fort Washington AvenueNew York, NY 10032

  • Book by Phone+1(229) 360-6868

Overview of  Dr. Hur

Dr. Chin Hur is a gastroenterologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Johns Hopkins University School of Medicine and has been in practice 22 years. He specializes in esophagus disease and gastrointestinal cancer.

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Gastroenterology, 1999 - 2002
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1995 - 1998
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1995

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2018 - 2027
  • MA State Medical License
    MA State Medical License 1998 - 2019
  • Gastroenterology
    American Board of Internal Medicine Gastroenterology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Survival Disparities by Race and Ethnicity in Early Esophageal Cancer  
    Chin Hur, Ryan Nipp, Digestive Diseases and Sciences

Authored Content

  • Mo1123 CRYOTHERAPY (TRUFREEZE™) VS. RADIO FREQUENCY ABLATION (BARRX™) FOR THE TREATMENT OF BARRETT’S ESOPHAGUS WITH HIGH-GRADE DYSPLASIA AND/OR EARLY ADENOCARCINOMA: AD INTERIM RESULTS OF A NON-INFERIORITY RANDOMIZED CLINICAL TRIALMay 2018
  • Mo1123 CRYOTHERAPY (TRUFREEZE™) VS. RADIO FREQUENCY ABLATION (BARRX™) FOR THE TREATMENT OF BARRETT’S ESOPHAGUS WITH HIGH-GRADE DYSPLASIA AND/OR EARLY ADENOCARCINOMA: AD INTERIM RESULTS OF A NON-INFERIORITY RANDOMIZED CLINICAL TRIALMay 2018

Press Mentions

  • Velocity Raises More Than $1.1 Million to End Cancer
    Velocity Raises More Than $1.1 Million to End CancerNovember 28th, 2022
  • Gastric Bypass Better for Type 2 Diabetics
    Gastric Bypass Better for Type 2 DiabeticsFebruary 16th, 2022
  • Gastric Bypass Most Cost-Effective for Severe Obesity, T2D?
    Gastric Bypass Most Cost-Effective for Severe Obesity, T2D?February 14th, 2022
  • Join now to see all

Grant Support

  • Coordinating Center for the Program on the Origins of Gastroesophageal CancersCOLUMBIA UNIVERSITY HEALTH SCIENCES2022–2027
  • Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by GenotypeCOLUMBIA UNIVERSITY HEALTH SCIENCES2021–2026
  • Comparative modeling of gastric cancer disparities and prevention in the US and globallyCOLUMBIA UNIVERSITY HEALTH SCIENCES2021–2026
  • Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by GenotypeCOLUMBIA UNIVERSITY HEALTH SCIENCES2021–2026
  • A Personalized Approach to Targeted Esophageal Cancer ScreeningCOLUMBIA UNIVERSITY HEALTH SCIENCES2020–2025

Professional Memberships

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    BCBS Massachusetts Blue Care Elect PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Great West PPO
    Harvard Pilgrim HMO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    Tufts Health Plan PPO
    UniCare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Chin Hur, Dr. Chin Hur, MD, Dr. C Hur